LINC00607 affects the proliferation and apoptosis of A549/DDP cells through inhibiting miR-372

Abstract

Abstract: Objective To explore the effect of LINC00607 on proliferation and apoptosis of lung cancer cisplatin-resistant cell line(A549/DDP) and its possible molecular mechanism. Methods The expressions of LINC00607 and miR-372 in lung cancer tissues, adjacent tissues, A549, A549/DDP cells were detected by real-time fluorescence quantitative PCR(RT-qOCR). A549/DDP cells were divided into pcDNA3.1 group, pcDNA3.1-LINC00607 group, (pcDNA3.1-LINC00607 + miR-NC)group, (pcDNA3.1-LINC00607 + miR-372)group. Methyl thiazolyl tetrazolium (MTT) assacy and colony formation experiments were used to test cell proliferation; flow cytometry was used to measure apoptosis; and Western blot was used to detect the expression levels of cleared-caspase-3 and Ki67; Dual luciferase reporter gene and RT-qPCR experiments confirmed the targeted regulation effect of LINC00607 on miR-372. Results Compared with adjacent tissues, the expression of LINC00607 in lung cancer tissues was significantly reduced, while the expression of miR-372 was significantly increased (P＜0.05). Compared with A549 cells, the expression of LINC00607 in A549/DDP cells was significantly reduced, while the expression of miR-372 was significantly increased (P＜0.05). Compared with pcDNA3.1 group, A549/DDP cell survival rate, clone formation numbers, Ki67 protein expression in pcDNA3.1-LINC00607 group were significantly decreased, and apoptosis rate and cleared-caspase-3 protein expression were significantly increased (P＜0.05). Compared with the (pcDNA3.1-LINC00607 + miR-NC)group, the A549/DDP cell survival rate, clone formation, Ki67 protein expression in the (pcDNA3.1-LINC00607 + miR-372)group were significantly increased, and the apoptosis rate, cleared-caspase-3 protein expression were significantly reduced (P＜0.05). LINC00607 targeted at and negatively regulated miR-372 expression. Conclusions LINC00607 inhibits proliferation and induces apoptosis of A549/DDP cells by down-regulating miR-372.

Key words: LINC00607, miR-372, A549/DDP cell line, drug resistance sensitivity

CLC Number:

R735

YANG Wen-chuan, HAN Dong, YANG Fan. LINC00607 affects the proliferation and apoptosis of A549/DDP cells through inhibiting miR-372[J]. Basic & Clinical Medicine, 2021, 41(7): 1001-1006.

References

[1]Nagasaka M, Gadgeel SM. Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer[J]. Expert Rev Anticancer Ther, 2018, 18: 63-70.
[2]Sun QM, Hu B, Fu PY, et al. Long non-coding RNA 00607 as a tumor suppressor by modulating NF-κB p65/p53 signaling axis in hepatocellular carcinoma[J]. Carcinogenesis, 2018, 39: 1438-1446.
[3]Zhao B, Xu H, Ai X, et al. Expression profiles of long noncoding RNAs in lung adenocarcinoma[J]. Onco Targets Ther, 2018, 11: 5383-5390.
[4]Wang C, Wang C, Qiu C, et al. Targeted regulation of FoxO3a by miR-372 to mediate gastric carcinoma cell apoptosis and DDP drug resistance[J]. Cancer Biother Radiopharm, 2020. doi: 10.1089/cbr.2019.3299.
[5]Wang Q, Liu S, Zhao X, et al. miR-372-3p promotes cell growth and metastasis by targeting FGF9 in lung squamous cell carcinoma[J]. Cancer Med, 2017, 6: 1323-1330.
[6]Liu B, Pan CF, Ma T, et al. Long non-coding RNA AK001796 contributes to cisplatin resistance of non small cell lung cancer[J]. Mol Med Rep, 2017, 16: 4107-4112.
[7]Sun J, Pan LM, Chen LB, et al. LncRNA XIST promotes human lung adenocarcinoma cells to cisplatin resistance via let-7i/BAG-1 axis[J]. Cell Cycle, 2017, 16: 2100-2107.
[8]曾玮, 陈平. 利用基因芯片重注释筛选肝细胞肝癌术后复发相关lncRNA[J].肿瘤学杂志, 2017, 23: 658-662.
[9]熊焕文, 夏国际, 吴冠楠. 晚期肺腺癌患者Ki-67表达水平与临床疗效的关系[J]. 医学研究生学报, 2018, 31: 55-58.
[10]杨忠信, 黄志昂, 潘丽红, 等. TPX2对人肺癌细胞增殖、凋亡及cleaved caspase-3表达的影响[J]. 解剖与临床, 2018, 23: 155-159.
[11]代会博, 马邦云, 张弘, 等. 升麻鳖甲汤加减方对人急性髓系白血病HL-60细胞增殖、凋亡及MAPK信号通路相关蛋白表达的影响[J]. 中医杂志, 2020, 61: 435-441.
[12]Tian LJ, Wu YP, Wang D, et al. Upregulation of long noncoding RNA (lncRNA) X-inactive specific transcript (XIST) is associated with cisplatin resistance in non-small cell lung cancer (NSCLC) by downregulating microRNA-144-3p[J]. Med Sci Monit, 2019, 25: 8095-8104.
[13]Sun H, Gao D. Propofol suppresses growth, migration and invasion of A549 cells by down-regulation of miR-372[J]. BMC Cancer, 2018, 18: 1252-1262.
[14]Yeh LY, Yang CC1, Wu HL, et al. The miR-372-ZBTB7A oncogenic axis suppresses TRAIL-R2 associated drug sensitivity in oral carcinoma[J]. Front Oncol, 2020, 10: 47-57.

[1]	ZHONG Ming, YU Xiu-yi, GUO Wei-xi, FANG Zheng. Ophiopogonin B inhibits proliferation and migration of human esophageal squamous cell carcinoma cell line EC9706 [J]. Basic & Clinical Medicine, 2022, 42(7): 1053-1059.
[2]	XIE Si-an, XU Jun-xuan, NING Ting-ting, ZHANG Nan, ZHU Sheng-tao, LIU Si. VAV1 is a potential target and a new biomarker for the prognosis of atherosclerosis [J]. Basic & Clinical Medicine, 2022, 42(7): 1092-1098.
[3]	CHEN Xi, PANG Hai-yu, QIN Chun-di, GUO Yuan-hong, YANG Ai-ming, LAI Ya-min. Short-term semi-immersion training based on a learning pyramid model theory can improve the capacity building to find early gastric cancer [J]. Basic & Clinical Medicine, 2022, 42(4): 696-700.
[4]	SUN Quan-peng, FAN Chao, ZHAN De-xi, FAN Yi-ming, SUN Wei-feng. Ropivacaine inhibits proliferation, migration and invasion of human liver cancer cell line Hep3B [J]. Basic & Clinical Medicine, 2022, 42(3): 448-453.
[5]	NIU Shi-wei, SU Yun, GONG Hong-xia, LI Ting-ting, ZENG Yuan-ding, ZHANG Han, NIE Peng. Increased serum IL-1 level and activated JAK2/STAT3 signaling pathway of cancer tissue in patients with gastric cancer [J]. Basic & Clinical Medicine, 2022, 42(3): 401-405.
[6]	HUANG Rong, ZHANG Jian, CHE Xu. Effect of SLC4A10 expression on prognosis of patient with hepatocellular carcinoma [J]. Basic & Clinical Medicine, 2022, 42(3): 461-466.
[7]	LIU Ming-sheng, CHEN Wen-chao, CAI Ying-chang. Down-regulation of lncRNA DNM3OS enhances radiotherapy sensitivity of human rectal cancer cell line SW-480 by targeting miR-193a-3p [J]. Basic & Clinical Medicine, 2022, 42(2): 260-267.
[8]	ZENG Di, ZHANG Cong-min, GUO Jin-pei, ZHANG Nan, MA Er-min. miR-125 attenuates LPS-induced transition of colorectal epithelial cells into cancer cells through targeting SMAD4 [J]. Basic & Clinical Medicine, 2022, 42(2): 249-254.
[9]	LYU Xue, LI Xue-wei, YANG Ting, ZHENG Jin-xiu, ZHU Zi-he, YANG Tao, XU Jun. Bioinformatic analysis of adenocarcinoma at esophagogastric junction and mutation sites screening of Involucrin gene [J]. Basic & Clinical Medicine, 2022, 42(2): 235-242.
[10]	SHI Tie-wei, LI Tian-zhu, ZHOU Jing, NA Ri-su, SUN Qi, XU Li-yan, BAI Chun-ying. Effects of 5-lipoxygenase activating protein inhibitor MK886 on proliferation and apoptosis of human esophageal cancer cell lines [J]. Basic & Clinical Medicine, 2022, 42(1): 56-61.
[11]	. Lycorine hydrochloride inhibits the proliferation, migration and invasion of gastric cancer cell line MGC-803 [J]. Basic & Clinical Medicine, 2021, 41(12): 1767-1773.
[12]	. Advances in the role of interferon-induced proteins with tetratricopeptide repeats (TPR) in digestive system tumors [J]. Basic & Clinical Medicine, 2021, 41(11): 1662-1665.
[13]	. Hydroxysafflor yellow A inhibits epithelial-mesenchymal transition in hepatocellular carcinoma cell line Huh7 [J]. Basic & Clinical Medicine, 2021, 41(10): 1423-1427.
[14]	. Progress in research on autophagy and hepatocellular carcinoma [J]. Basic & Clinical Medicine, 2021, 41(10): 1514-1517.
[15]	HOU Nan, LIU Yuan, GAO Jun, WANG Jing. miR-141-3p inhibits the migration and invasion of gastric cancer cell line AGS through targeting PDCD1 [J]. Basic & Clinical Medicine, 2021, 41(9): 1297-1302.